Stress management : Techniques like meditation, yoga, and deep breathing can reduce stress, which can be a barrier to weight loss
Direct cellular delivery
This reduces the risk of diabetic ketoacidosis, and you should contact your healthcare team for guidance on when to restart treatment
Therefore, given the widespread use of incretin agonists for obesity treatment and weight loss, it is important to recognize their effects in the gastrointestinal tract, which could constitute significant benefits in weight loss and cardiometabolic benefits, but can be associated with adverse effects that constitute a potential barrier to their use, particularly at higher doses
However, alongside their benefits, a growing number of patients have reported severe and sometimes life-altering side effects, leading to a wave of GLP-1 drugs personal injury lawsuits across the nation as of 2026
Available at Kirzinger A, Lopes L, Muana C, et al